Thibela TB Trisha Crawford James Lewis Katherine Fielding.

Slides:



Advertisements
Similar presentations
MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop Household Questionnaire: Education.
Advertisements

Draft Generic Protocol: Measuring Impact and Effectiveness of National Programs for Prevention of Mother-To-Child HIV Transmission at Population-Level.
1 Incorporating Statistical Process Control and Statistical Quality Control Techniques into a Quality Assurance Program Robyn Sirkis U.S. Census Bureau.
International Guidance on Methods to Measure PMTCT Impact Chika Hayashi Strategic Information, HIV Department WHO.
Development of extensive drug resistance in Multi-Drug resistant tuberculosis patients MSF anti-TB programmes in Abkhazia and Uzbekistan Authors: Cathy.
Utilizing Facility Data for Program Monitoring Valerie Koscelnik Track 1 ART Program Meeting Maputo, August 12, 2010.
Elements of a clinical trial research protocol
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
How do nurses use new technologies to inform decision making?
Chengbin Hu Obese and overweight: problem and how to control? Problem: More than 2 in 3 adults are considered to be overweight or obese. More.
1 Randomization as a Concept to Improve Follow-Up and Reduce Cost in Long-Term Health Related Quality of Life Studies Addressing Cardiac Surgery Scott.
Agenda: Block Watch: Random Assignment, Outcomes, and indicators Issues in Impact and Random Assignment: Youth Transition Demonstration –Who is randomized?
Sample Size Determination
Long-term predictive value of assessment of coronary atherosclerosis by contrast- enhanced coronary computed tomography angiography: meta- analysis and.
Southern Africa out of control Swaziland South Africa Namibia Botswana Zimbabwe Lesotho Zambia
Secondary School Bursaries Kenya impact Evaluation Team AFRICA IMPACT EVALUATION INITIATIVE, AFTRL Africa Program for Education Impact Evaluation.
Building a database for children with disabilities using administrative data and surveys Adele D. Furrie September 29, 2011.
Factors that Associated with Stress in Nursing Faculty in Thailand
Weight gain during treatments is commonly found in many patients with severe mental illness (SMI) and is found during treatment with most psychotropic.
Measuring Output from Primary Medical Care, with Quality Adjustment Workshop on measuring Education and Health Volume Output OECD, Paris 6-7 June 2007.
Impact Evaluation in the Real World One non-experimental design for evaluating behavioral HIV prevention campaigns.
Journal Club Hallie Lee PharmD Candidate 2013 Mercer University COPHS PHA 618 Geriatrics-Continuous Care Multivitamins in the Prevention of Cardiovascular.
Johns Hopkins Center for Tuberculosis Research
Embedding Open-label PrEP trial in expansion of UK HIV Prevention Programme.
Effects of an HIV/AIDS peer prevention intervention on sexual and injecting risk behaviors among injecting drug users (IDUs) and their risk partners in.
Implementing Adult Risk Factor Surveillance in Manitoba Case Studies ARFS Symposium January 26, 2011.
Nomsa Mulima 17 th July 2011 Effectiveness of the PMTCT program in Swaziland.
1 Sources of gender statistics Angela Me UNECE Statistics Division.
United Nations Economic Commission for Europe Statistical Division Sources of gender statistics Angela Me UNECE Statistics Division.
Generic protocol for national population-based impact evaluation of national programs for PMTCT at 6 weeks post-partum Thu-Ha Dinh, MD., MS., US CDC/GAP.
WIHS was established in 1993 to investigate the impact and progression of HIV in women.
TB prevention: new data, new approaches, new challenges Improving health worldwide Alison Grant London School of Hygiene & Tropical Medicine.
Discussion for a statement for biobank and cohort studies in human genome epidemiology John P.A. Ioannidis, MD International Biobank and Cohort Studies.
CREATE Biostatistics Core THRio Statistical Considerations Analysis Plan.
1 THE ROLE OF COVARIATES IN CLINICAL TRIALS ANALYSES Ralph B. D’Agostino, Sr., PhD Boston University FDA ODAC March 13, 2006.
Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
How to read a paper D. Singh-Ranger. Academic viva 2 papers 1 hour to read both Viva on both papers Summary-what is the paper about.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Effect of community-wide isoniazid preventive therapy on tuberculosis among South African gold miners “Thibelo TB” Aurum Health Research LSHTM JHU Gold.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Data dissemination meeting February 28, 2007 ICAP New York.
Designs of Quasi-Experiments Studies for Assessing the Transport Enhancements and Physical Activity.
The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.
Building a database for children with disabilities using administrative data and surveys Adele D. Furrie September 27, 2011.
CREATE Biostatistics Core Functions Summary of activities Challenges / coming year’s activities.
Background Appropriate time to start HAART is still debatable 1995: “Time to hit HIV, early and hard” Eradication thought to be possible Early regimens.
Effects of breastfeeding on outpatient visits and hospitalizations during the first 18 months of life in Hong Kong Chinese infants Leung GM, Ho LM, Lam.
BluePrint for Health® stop-smoking program: Quit Outcomes Nina L. Alesci, M.P.H. Blue Cross and Blue Shield of Minnesota* Center for Tobacco Reduction.
Personal Health Budgets Evaluation Evaluation of the Personal Health Budgets Pilots Wider Cohort Pilot Sites.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
CREATE Biostatistics Core THRio Statistical Considerations Analysis of baseline data—esp. truncation Analysis of main study data—esp. correlation.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
Applying RDS to assess risk & protective factors and HIV related risk behaviors among young men who have sex with men (YMSM) Dr. Myo Myo.
Comments to “The effects of Ecuador’s economic crisis on child health and cognitive development” by Melissa Hidrobo Eduardo Rodríguez-Oreggia EGAP ITESM.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Post-It Notes to Improve Questionnaire Response Rates in RCTs Findings from a Randomised Sub-Study Ada Keding 1, Helen Lewis 2, Kate Bosanquet 2, Simon.
Successfully enrolled in HIV Care but not linked to timely Treatment: Poor retention and Monitoring of Pre-ART patients who are not yet eligible for ART.
Table 1. Methodological Evaluation of Observational Research (MORE) – observational studies of incidence or prevalence of chronic diseases Tatyana Shamliyan.
Response Burden Measurement Ashu Conrad October 2012.
ZAMSTAR restricted randomisation CREATE Investigators Meeting 2005 Charalambos (Babis) Sismanidis LSHTM.
J Browne, DA Edwards, KM Rhodes, DJ Brimicombe, RA Payne
Differentiated Monitoring & Evaluation
Guidance on completion of Isoniazid Preventive Therapy register
Presented at the American Diabetes Association
Clinicaltrials.gov Update
UMRG 3rd Learning Session: July 19th, 2012
How to read a paper D. Singh-Ranger.
S1316 analysis details Garnet Anderson Katie Arnold
Tuberculosis Global Epidemiology
Presentation transcript:

Thibela TB Trisha Crawford James Lewis Katherine Fielding

Statistical analysis plan Measurement of the primary outcome Measurement of the primary outcome Sub-group analyses Sub-group analyses –Hostel dwellers or permanent employees –HIV prevalence amongst TB cases

Original plan for study 12 mths24 mths Max. of 3 mths recruitment 12 mths measurement period for primary outcome Final prevalence survey Baseline prevalence survey Staggered enrolment across regions

Revised plan for study 9 mths: last participant to start IPT completes IPT Recruitment Period: variable for each cluster (depending on cluster size) 12 mths: measurement period for primary outcome Final prevalence survey Date of cluster enrolment Baseline prevalence survey Extended recruitment and follow-up Co-enrol in regions

Definition of time period for primary outcome Start of measurement period Start of measurement period –cluster enrolment + cluster-specific recruitment period + 9 months Control clusters we define a cluster-specific recruitment period based on Control clusters we define a cluster-specific recruitment period based on –Size of cluster –Assuming recruitment 30/day, 5 recruitment days per mth For smaller clusters the measurement period starts a shorter time interval after cluster enrolment For smaller clusters the measurement period starts a shorter time interval after cluster enrolment

Adjustment Individual level Individual level –Age, gender, surface/underground, permanent/contractor Cluster level Cluster level –TB CNRs, ART/IPT coverage, radiological prevalence of TB, silicosis

Analyses planned- Baseline survey Baseline survey Baseline survey –RFs for being on TB Rx, radiological prevalence of TB Use of survey for cohort analysis Use of survey for cohort analysis –RFs for TB –Effect of secondary PT (restricted to those reporting prev hx of TB)

Analyses of data from intervention clusters TB case finding TB case finding Screening failures on IPT Screening failures on IPT Retention analysis Retention analysis –Report to DSMB

Final culture prevalence survey Sample size Sample size –750 per cluster –Based on 60% reduction in TB prevalence Clusters range in size from 1000 to 11,000 Clusters range in size from 1000 to 11,000 Longer FU of clusters would be beneficial (routine FU) Longer FU of clusters would be beneficial (routine FU) To minimize the impact survey on outcome - sample proportionally to cluster size? To minimize the impact survey on outcome - sample proportionally to cluster size?

TCAS – TB case ascertainment study Problems Problems –Differential up-take by intervention arm; information on refusals is documented –Compare counts by time period with TB register –Contractors? Case definitions for outcomes Case definitions for outcomes –? Compare across studies

Other data sources ART/IPT availability ART/IPT availability –Baseline & collected direct from company Health services (aggregate data at cluster level) Tolerability sub-study Tolerability sub-study –Add in more mixing questions? HR data HR data –Presented a crude summary of in and out- migration –More detailed analysis

Papers Pilot studies Pilot studies –TST & TB survey –INH urine testing Study design paper Study design paper TB case-finding TB case-finding MGIT demonstration study (incl. economics) MGIT demonstration study (incl. economics) Modelling Modelling Data management? Data management? AEs – short report? AEs – short report?